Intrathecal administration of Cav3.2 inhibitor (2R/S)-6-PNG alleviated the mechanical and thermal sensitivity of mice caused by VZV, further illustrating that Cav3.2 played a key role in zoster-associated pain and had the potential to be a novel drug target. Here, CACNA1H is linked to herpes zoster.